See analyst estimates and all valuation multiples for Drug Delivery Systems
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $22.2B | 8.8x | 37.0x | |
| $9.0B | 376.8x | -8.4x | |
| $7.2B | 5.4x | 21.7x | |
| $4.2B | n/a | n/a | |
| $3.6B | 13.5x | 34.7x | |
| $3.5B | 3.0x | 10.7x | |
| $2.2B | 38.8x | -8.7x | |
| $2.0B | 32.5x | n/a | |
| $1.7B | n/a | n/a | |
| $1.6B | 5.0x | n/a | |
| $1.4B | 40.9x | -197.7x | |
| $751M | 19.9x | -3.9x | |
| $613M | 7.5x | -204.2x | |
| $519M | n/a | n/a | |
| $437M | 90.7x | -3.9x | |
| $327M | 27.4x | -231.1x | |
| $283M | n/a | n/a | |
| $249M | 3.2x | 13.0x | |
| $240M | 5.6x | -12.2x | |
| $192M | n/a | n/a | |
| $152M | 33.8x | n/a | |
| $128M | n/a | n/a | |
| $122M | 56.1x | -5.3x | |
| $118M | 310.8x | n/a | |
| $96.7M | 4.6x | -63.2x | |
| $86.7M | 15.6x | -20.1x | |
| $82.8M | 18.0x | -3.7x | |
| $80.0M | n/a | n/a | |
| $75.4M | 28.8x | n/a | |
| $59.2M | n/a | n/a | |
| $55.1M | n/a | n/a | |
| $48.7M | 7.5x | -11.7x | |
| $46.1M | 316.6x | n/a | |
| $40.3M | n/a | n/a | |
| $25.4M | n/a | -1.6x | |
| $25.0M | 23.6x | n/a | |
| $17.4M | 25.3x | n/a | |
| $12.2M | n/a | n/a | |
| $10.9M | 4.8x | -0.4x | |
| $2.0M | n/a | n/a | |
| $1.4M | 0.8x | n/a | |
| -$3.9M | -1.4x | n/a | |
| -$37.2M | -0.5x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Drug Delivery Systems